Accelerating Drug Discovery With Real-Time Kinetic and Affinity Analysis

To improve decision-making in drug development, researchers need instruments that allow them to obtain high-quality kinetics data. The Creoptix WAVEsystem, based on GCI technology, provides label-free interaction analysis allowing you to obtain kinetic and affinity data, alongside evaluation of binding specificity, in real-time.

Download this whitepaper highlighting four case studies which demonstrated that the Creoptix WAVEsystem can:

Determine the binding kinetics of 146 drug HIT compounds in hours
Reduce HIT screening campaigns from weeks to days
Provide you with sensitive and rapid label-free analysis
Directly characterize antibodies from clinical blood plasma samples
Screened crude-reaction mixtures (CRMs) for affinity with minimal sample purification

I agree to share the above information with Malvern Panalytical and understand that I may receive materials and communications from Malvern Panalytical about their products and services.

By submitting your data, you are giving consent to the collection, processing and use of your personal data in accordance with Malvern Panalytical’s privacy policy.

Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.